Boston Scientific insider buys: CFO Monson Jonathan’s July 1 purchase shows steady confidence, hinting at long‑term upside for the medical‑device stock.
CEO Adam Kalbermattens’ $0 PSU deal and board buying signal confidence in Koru Medical’s 2030 growth targets, hinting at a potential breakout for this volatile medical‑device stock.
Tsai Chen Lung’s June 30 insider buy of 2,022 shares at $7.58 signals strong confidence in CAPSOVISION’s future, with a new risk officer and rising social‑media buzz.
Harris Taylor’s 2026 insider stock‑unit awards at Establishment Labs signal executive confidence, hinting at upcoming product launches and a potential earnings turnaround.